Home›Companies›Biotech & Pharma›AstralBio

AstralBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 19, 2024·Suggest an edit

About AstralBio

AstralBio is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $957,408 raised in one offering on Form D since December 2024. Its chief executive is Patrick Crutcher.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 10, 2024Dec 19, 2024$957,408fully sold2$478KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AstralBio's Form D filed Dec 19, 2024.

JD
Justin DiMartino
Executive officer and director
PC
Patrick Crutcher
Chief Executive Officer and director

Sources

  1. SECAstralBio, Inc. filing history